Asploro Journal of Biomedical and Clinical Case Reports

Asploro Journal of Biomedical and Clinical Case Reports

Hiroshi Bando^1,2*
1Tokushima University/Medical Research, Tokushima, Japan
²Integrative Medicine Japan (IMJ), Shikoku Island Division, Tokushima, Japan

Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ^{ORCID iD}
Address: Tokushima University/Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 18 March 2021; Accepted date: 29 March 2021; Published date: 06 April 2021

Citation: Bando H. Fewer Annual Deaths in Japan with Negative Excess Mortality for COVID-19. Asp Biomed Clin Case Rep. 2021 Apr 06;4(1):84-87.

Copyright © 2021 Bando H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Keywords: COVID-19, Excess Mortality, Years of Life Lost, Ministry of Health, Labour and Welfare, Japan

Abbreviations: YLL: Years of Life Lost; MHLW: Ministry of Health, Labour and Welfare

Abstract

The excess mortality would be adequate objective indicator for COVID-19 research, and was reported in 77 countries for 2020. Several representative data are: United States 420,000, Mexico 270,000, Russia 270,000, Brazil 170,000, Japan -15,000, Taiwan -4,800, Australia -4,700 and New Zealand -2,100. From demographics in Japan, the number of deaths increased by 18 thousand each year during 2015-2019. However, death in 2020 decreased by 9,373 from 2019, which indicated 27 thousand difference. A meaningful perspective showed that focusing on human life saves the economy. Future crucial factors would be new ways of working with the ability of human resources.